全文获取类型
收费全文 | 1337440篇 |
免费 | 98169篇 |
国内免费 | 2227篇 |
专业分类
耳鼻咽喉 | 19183篇 |
儿科学 | 44107篇 |
妇产科学 | 38918篇 |
基础医学 | 194055篇 |
口腔科学 | 36729篇 |
临床医学 | 114304篇 |
内科学 | 263983篇 |
皮肤病学 | 27463篇 |
神经病学 | 105409篇 |
特种医学 | 52161篇 |
外国民族医学 | 371篇 |
外科学 | 208352篇 |
综合类 | 27262篇 |
现状与发展 | 1篇 |
一般理论 | 391篇 |
预防医学 | 97739篇 |
眼科学 | 30313篇 |
药学 | 101793篇 |
1篇 | |
中国医学 | 2601篇 |
肿瘤学 | 72700篇 |
出版年
2018年 | 13423篇 |
2016年 | 11245篇 |
2015年 | 12891篇 |
2014年 | 18002篇 |
2013年 | 27189篇 |
2012年 | 37827篇 |
2011年 | 40441篇 |
2010年 | 23649篇 |
2009年 | 22187篇 |
2008年 | 38953篇 |
2007年 | 42087篇 |
2006年 | 42572篇 |
2005年 | 41865篇 |
2004年 | 40207篇 |
2003年 | 38881篇 |
2002年 | 38199篇 |
2001年 | 58579篇 |
2000年 | 60014篇 |
1999年 | 51244篇 |
1998年 | 14903篇 |
1997年 | 13404篇 |
1996年 | 13598篇 |
1995年 | 12799篇 |
1994年 | 12201篇 |
1993年 | 11247篇 |
1992年 | 41302篇 |
1991年 | 40670篇 |
1990年 | 40148篇 |
1989年 | 38952篇 |
1988年 | 36362篇 |
1987年 | 35583篇 |
1986年 | 33961篇 |
1985年 | 32469篇 |
1984年 | 24318篇 |
1983年 | 21161篇 |
1982年 | 12858篇 |
1981年 | 11385篇 |
1980年 | 10605篇 |
1979年 | 22817篇 |
1978年 | 16138篇 |
1977年 | 13970篇 |
1976年 | 13164篇 |
1975年 | 14403篇 |
1974年 | 16849篇 |
1973年 | 16239篇 |
1972年 | 15448篇 |
1971年 | 14335篇 |
1970年 | 13295篇 |
1969年 | 12805篇 |
1968年 | 12049篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
991.
Onur Hapa Hüsamettin ?ak?c? Kaan Gidero?lu Kutay ?zturan Aysel Kükner Güler Bu?dayc? 《Archives of orthopaedic and trauma surgery》2009,129(12):1721-1726
Introduction
Ethanol has a suppressive effect on inflammation and the immune system, but the effect of ethanol on tendon healing in vivo has not been studied. The purpose of this study was to investigate the histological and biomechanical effects of ethanol intake on tendon healing in a rat tendon injury model. 相似文献992.
993.
994.
Objectives
For individuals not on antiretroviral therapy, the risk of heterosexual transmission of HIV appears negligible when blood plasma (BP) viral loads are <1500 HIV‐1 RNA copies/mL. It is not clear whether this observation can be extrapolated to individuals on highly active antiretroviral therapy (HAART). Because of differential tissue penetration, antiretroviral drug concentrations may be sufficient to maintain an undetectable viral load in the BP yet not achieve adequate levels to suppress HIV in the genital tract. Therefore, we wanted to correlate HIV viral loads and drug concentrations in semen plasma (SP) and BP.Methods
Thirty‐three men were included. All were on combination antiretroviral therapy with an undetectable BP viral load for at least 1 year. Blood and semen samples were collected within 2 h of each other and tested for HIV RNA by the NucliSens QT (bioMerieux, St Laurent, QC, Canada) method; drug concentrations were determined by liquid chromatography tandem mass spectrometry.Results
Two of the 33 patients (6.1%) with BP viral loads below detection had time‐matched HIV viral loads in SP ≥700 copies/mL. Both patients were on efavirenz, the SP concentrations of which were ≤10% of the levels in BP and well below the minimal therapeutic drug monitoring target concentration required to suppress HIV.Conclusions
Because, at least in part, of poor drug penetration into the genital tract, an undetectable HIV viral load in the BP does not guarantee an undetectable viral load in semen. In view of this, caution should be taken in concluding that patients on HAART with suppressed viraemia are sexually non‐infectious. 相似文献995.
996.
Breast cancer is the female malignant neoplasia with the highest incidence in the industrialized world. Despite many undeniable therapeutic successes obtained, breast cancer still remains, however, a major health issue. In the last few years, thanks to aromatase inhibitors, the hormone therapy for oestrogen-dependent breast cancer has evolved in terms of efficacy and tolerability; at the same time, it has enabled us to better define the role of oestrogens in the etiopathogenesis of this tumour. Weight increase and obesity have been identified as the most important risk and prognostic factors for breast cancer in postmenopausal women. Several hypotheses have been proposed to explain the association of obesity with postmenopausal breast cancer. A more recent hypothesis suggests that adipocytes and their autocrine (paracrine and endocrine actions) are at the centre of such an etiopathogenetic mechanism. A better understanding of the main mechanisms that link together menopause, body-weight increase and hormone-dependent breast cancer is paramount to enable the identification of key molecules involved in the development of breast carcinoma and suggest new therapeutic options. The present review will discuss important findings on the therapeutic aspects of adipose tissue and adipokines as a target for treatment of hormone-dependent breast cancer. 相似文献
997.
998.
Betsy D. Kennard Susan G. Silva Simon Tonev Paul Rohde Jennifer L. Hughes Benedetto Vitiello Christopher J. Kratochvil John F. Curry Graham J. Emslie Mark Reinecke John March 《Journal of the American Academy of Child and Adolescent Psychiatry》2009,48(2):186-195
ObjectiveWe examine remission rate probabilities, recovery rates, and residual symptoms across 36 weeks in the Treatment for Adolescents with Depression Study (TADS).MethodThe TADS, a multisite clinical trial, randomized 439 adolescents with major depressive disorder to 12 weeks of treatment with fluoxetine, cognitive–behavioral therapy, their combination, or pill placebo. The pill placebo group, treated openly after week 12, was not included in the subsequent analyses. Treatment differences in remission rates and probabilities of remission over time are compared. Recovery rates in remitters at weeks 12 (acute phase remitters) and 18 (continuation phase remitters) are summarized. We also examined whether residual symptoms at the end of 12 weeks of acute treatment predicted later remission.ResultsAt week 36, the estimated remission rates for intention-to-treat cases were as follows: combination, 60%; fluoxetine, 55%; cognitive–behavioral therapy, 64%; and overall, 60%. Paired comparisons reveal that, at week 24, all active treatments converge on remission outcomes. The recovery rate at week 36 was 65% for acute phase remitters and 71% for continuation phase remitters, with no significant between-treatment differences in recovery rates. Residual symptoms at the end of acute treatment predicted failure to achieve remission at weeks 18 and 36.ConclusionsMost depressed adolescents in all three treatment modalities achieved remission at the end of 9 months of treatment. 相似文献
999.
1000.